Clinical trial

Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in…

NCT00005838 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00005838
Title Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
Official title Multicenter, Open-Ended, Double-Blind, Placebo-Controlled, Phase III Study of AE-941 in Addition to Combined Modality Treatment (Chemotherapy/Radiotherapy) for Locally Advanced Unresectable Non-Small Cell Lung Cancer
Lead sponsor National Cancer Institute (NCI), NIH
Collaborators Radiation Therapy Oncology Group National Center for Complementary and Integrative Health (NCCIH) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
Intervention type Drug, Other, Radiation
Interventions shark cartilage extract AE-941, placebo, cisplatin, vinorelbine tartrate, carboplatin, paclitaxel, radiation therapy
Enrollment 756
Start date Mar 1, 2000
Primary completion Feb 1, 2007
First posted Jan 27, 2003
Last update posted Jan 23, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies